- Home
- ANDG vs VCYT Comparison
ANDG vs VCYT Comparison
Compare ANDG & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANDG | VCYT |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2025 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ANDG | VCYT |
|---|---|---|
| Price | $21.42 | $36.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $29.50 | ★ $46.00 |
| AVG Volume (30 Days) | 303.6K | ★ 839.8K |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | ★ $810,756,000.00 | $495,141,000.00 |
| Revenue This Year | $15.16 | $16.72 |
| Revenue Next Year | $16.08 | $11.31 |
| P/E Ratio | ★ $39.96 | $91.64 |
| Revenue Growth | ★ 26.86 | 16.41 |
| 52 Week Low | $19.41 | $22.61 |
| 52 Week High | $27.51 | $50.71 |
Technical Indicators
Market Signals| Indicator | ANDG | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 37.14 | 32.81 |
| Support Level | $19.41 | $34.71 |
| Resistance Level | $21.62 | $38.98 |
| Average True Range (ATR) | 1.59 | 1.76 |
| MACD | -0.17 | -0.58 |
| Stochastic Oscillator | 26.14 | 10.42 |
Price Performance
Historical ComparisonAbout ANDG Andersen Group Inc. Class A Common Stock
Andersen Group Inc is a provider of independent tax, valuation and financial advisory services to individuals and family offices, businesses and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.